Sartorius Biostat STR vs Thermo HyPerforma vs Cytiva Xcellerex: Single-Use Bioreactor Comparison
All three platforms deliver equivalent mixing time (below 30 s) and volumetric oxygen transfer (kLa above 10 h−¹) for standard CHO fed-batch mammalian cell culture from 50 L to 2,000 L, so raw hydrodynamics rarely decide the vendor. Choose Sartorius Biostat STR for the deepest CDMO installed base and integrated BioPAT + XCell ATF perfusion; choose Thermo HyPerforma when you need to scale past 2,000 L via the DynaDrive 5,000 L platform with 250 L minimum turndown; choose Cytiva Xcellerex XDR when you standardise on the Cytiva X-platform for continuous downstream and want an off-centred impeller with 5:1 turndown at commercial scale. Sartorius, Thermo, and Cytiva together hold just over 45% of 2024 SUB revenue.
Key differences at a glance
- Sartorius Biostat STR: top-driven magnetically coupled shaft with 2× 3-blade segment impellers, 50–2,000 L, Flexsafe STR bags, deepest CDMO adoption, factory-integrated Repligen XCell ATF option, ~15% market share.
- Thermo HyPerforma S.U.B.: bottom-mounted pitched-blade impeller, 50–2,000 L with 2:1 or 5:1 turndown BioProcess Container bags, and a separate DynaDrive line that extends to 3,000 L and 5,000 L cube-shaped vessels with 250 L minimum working volume — the only 5,000 L SUB on the market.
- Cytiva Xcellerex XDR: off-centred, four-pitched-blade bottom-mounted impeller, 10–2,000 L with 5:1 turndown, combined micro and macrosparger options, optional perfusion loading door at 1,000–2,000 L, integrates with the Cytiva ReadyToProcess X-platform continuous downstream stack.
- Best for scaling past 2,000 L: Thermo HyPerforma DynaDrive (only platform reaching 5,000 L).
- Best for CDMO tech transfer: Sartorius Biostat STR (installed at Samsung, WuXi, Boehringer Ingelheim).
Side-by-side comparison
| Factor | Sartorius Biostat STR | Thermo HyPerforma S.U.B. | Cytiva Xcellerex XDR |
|---|---|---|---|
| Working volume range | 50, 200, 500, 1,000, 2,000 L | 50, 100, 250, 500, 1,000, 2,000 L (S.U.B.); +50, 500, 3,000, 5,000 L (DynaDrive) | 10, 50, 200, 500, 1,000, 2,000 L |
| Impeller design | 2× 3-blade segment, top-driven magnetically coupled | Pitched-blade, bottom-mounted (S.U.B.); multi-impeller drive train (DynaDrive) | 4-pitched-blade, off-centred, bottom-mounted |
| Vessel geometry | Cylindrical jacketed stainless holder | Cylindrical (S.U.B.); cube-shaped (DynaDrive) | Cylindrical/rectangular jacketed holder |
| Bag family | Flexsafe STR (multi-use DO/pH or optical DO/pH options) | HyPerforma BioProcess Container (BPC) | Xcellerex XDR biocontainer |
| Turndown ratio | 4:1 typical (12.5 L minimum in 50 L) | 2:1 or 5:1 (S.U.B.); 12–20:1 (DynaDrive at 3–5K L) | 5:1 across full range |
| Published mixing time (2,000 L) | <20 s at typical tip speed | <30 s (5:1 S.U.B.); shorter at DynaDrive | <30 s (extrapolated from XDR-10 characterisation) |
| Published kLa (mammalian, ring/macrosparger) | >10 h−¹ standard, up to 40 h−¹ microsparger | >10 h−¹ standard; >600 h−¹ in SUF microbial variant | >10 h−¹ standard; up to 22.1 h−¹ at XDR-10 scale |
| Maximum single-vessel scale | 2,000 L | 5,000 L (DynaDrive) | 2,000 L |
| Native cell-retention integration | Integrated Repligen XCell ATF (Gen 3) | External ATF/TFF via HyPerforma perfusion recirculation system | Optional perfusion loading door (XDR-1000/2000) |
| Native automation platform | Biobrain (successor to BioPAT MFCS) | HyPerforma controller / DASGIP-derived software | DeltaV or AVEVA (Allen-Bradley PLC on XDR-2000) |
| Estimated 2024 SUB market share (vendor) | ~15% (single largest) | ~15% combined (Thermo) | ~15% combined (Cytiva/Danaher) |
Values reflect the vendors' published Generation 3 (Sartorius), classic S.U.B. 5:1 and DynaDrive (Thermo), and X-platform-refreshed XDR (Cytiva, March 2025) datasheets. Your current-datasheet specifications take precedence. See the single-use bioreactor selection guide for the stirred-tank vs wave vs fixed-bed decision upstream of vendor choice.
Sartorius Biostat STR in detail
The Sartorius Biostat STR, currently in its Generation 3 platform, is the workhorse single-use stirred-tank bioreactor for mammalian cell culture across process development, clinical manufacturing, and commercial biologics production. The family spans five vessel sizes — 50, 200, 500, 1,000, and 2,000 L working volume — and pairs with the Flexsafe STR bag family under a design paradigm Sartorius calls "one-for-all scale-up," where the same conical impeller geometry, sparger topology, and H/D ratio scale unchanged from 50 L bench to 2,000 L production.
How it works
The Biostat STR uses two 3-blade segmented impellers on a magnetically coupled centre-line shaft, top-driven by an AC motor sitting on the vessel head plate. The Flexsafe STR bag installs into a jacketed stainless-steel holder that provides thermal control (typical 4–40 °C for mammalian culture), load-cell weight measurement, and mechanical support during agitation. Gas delivery is via a choice of ring sparger (typical for macro-oxygenation with air/oxygen at 0.02–0.1 vvm) or micro sparger (used when the process pushes into higher kLa territory at high cell density). Published engineering characterisation by De Wilde et al. (2014, BioProcess International) reports mixing times of 2–20 s across the 2 L to 2,000 L scale range and kLa values greater than 10 h−¹ readily achievable at all scales, with up to 40 h−¹ at 2,000 L in microsparger operation. Sartorius Generation 3 adds factory-integrated Repligen XCell ATF hollow-fibre cell retention as a supported option for intensified fed-batch and perfusion, plus the Biobrain automation platform that replaces the legacy BioPAT MFCS control tower.
When Biostat STR wins
Sartorius wins on installed CDMO base and tech-transfer predictability. Biostat STR is the reference platform at Samsung Biologics (~784,000 L of commercial capacity across five plants in Songdo), WuXi Biologics, Boehringer Ingelheim BioXcellence, and much of the Sartorius-adjacent European CDMO fleet, so a process transferred from a Biostat STR PD line lands on an identical geometry at commercial scale. If your programme is CDMO-manufactured for clinical or commercial supply, the transfer risk is lowest here. The Generation 3 XCell ATF integration also makes it the smoothest platform for teams whose fed-batch strategy specifically needs perfusion-based N-1 seed generation.
Thermo HyPerforma S.U.B. and DynaDrive in detail
Thermo Fisher's single-use bioreactor portfolio spans two related product families. The HyPerforma S.U.B. is the classic cylindrical stirred-tank single-use bioreactor, available at 50, 100, 250, 500, 1,000, and 2,000 L in both 5:1 and 2:1 turndown geometries. The HyPerforma DynaDrive is the next-generation platform introduced to overcome mixing and mass-transfer ceilings at commercial scale — it uses a cube-shaped vessel and a novel multi-impeller drive train, and extends the range to 3,000 L and 5,000 L, the largest single-use bioreactor commercially available. Both families use HyPerforma BioProcess Container (BPC) bags with reusable BioProcess Controllers.
How it works
The classic HyPerforma S.U.B. uses a pitched-blade impeller on a bottom-mounted magnetically coupled shaft, driven by an AC motor and jacketed for thermal control. Two turndown geometries are offered per size: the 5:1 model has a taller aspect ratio (H/D ~2) for higher kLa at commercial scale and is preferred for microbial or high-cell-density mammalian; the 2:1 model has a wider H/D ~1 for gentle mixing and lower shear, preferred for shear-sensitive cell lines. The HyPerforma 5:1 S.U.B. brochure quantifies performance at each scale. The DynaDrive S.U.B. departs from the cylindrical stirred-tank archetype entirely: a cube-shaped vessel houses multiple impellers on a drive train that delivers higher power input per unit volume (P/V) than a classic S.U.B. at the same tip speed, achieving shorter mixing times, higher kLa, and lower minimum working volume. Thermo publishes a 250 L minimum working volume in the 3,000 L and 5,000 L DynaDrive vessels — a turndown of 12–20:1 — which lets a single seed train span two more generations without an intermediate vessel handoff. Thermo's own economics claim a 25% production-cost reduction versus a matched classic S.U.B. seed train through fewer reactors, less consumables, and less labour.
When HyPerforma wins
Thermo wins whenever the programme's mass-balance demands push past what a 2,000 L single-use bioreactor can deliver. DynaDrive 3,000 L and 5,000 L are the only commercially available single-use bioreactors above 2,000 L; if you want single-use disposables at that scale (for facility flexibility, faster changeover, or lower cleaning validation burden) HyPerforma is currently the only option. DynaDrive is also the strongest choice for consolidating a long seed train — the 12–20:1 turndown lets one vessel serve two seed generations, which reduces the number of reactors on the plant floor. On the classic S.U.B. side, Thermo wins in fill-finish-adjacent bioprocess facilities that already run the Thermo Fisher (formerly Life Technologies, Millipore) stack, and in fermentation applications via the HyPerforma SUF (Single-Use Fermentor) variant that achieves kLa greater than 600 h−¹ for microbial culture. The February 2025 Thermo Fisher acquisition of Solventum's Purification and Filtration business further strengthens Thermo's single-use portfolio.
Cytiva Xcellerex XDR in detail
The Cytiva Xcellerex XDR single-use stirred-tank family originated with Xcellerex Inc., was acquired by GE Healthcare, and is now marketed by Cytiva (part of Danaher). The XDR line spans XDR-10, XDR-50, XDR-200, XDR-500, XDR-1,000, and XDR-2,000 for cell culture applications with a consistent 5:1 turndown across the range. In March 2025 Cytiva expanded the "X-platform" branding to formally include the refreshed XDR-500 and XDR-2000 with tighter integration to the Cytiva ReadyToProcess X-station continuous downstream infrastructure — the Xcellerex XDR is now the upstream anchor for Cytiva's end-to-end continuous manufacturing story.
How it works
The Xcellerex XDR uses a distinctive off-centred, bottom-mounted impeller with four pitched blades on a magnetically coupled shaft driven from below. The off-centre placement provides asymmetric flow that avoids the central vortex of a conventional centre-line stirred tank and improves gas dispersion at low agitation rates. Sparging is via two families of interchangeable elements: microsparger with 2 μm or 20 μm nominal pore size for high-kLa oxygen delivery, and drilled-hole macrosparger with 0.5 mm or 1.0 mm holes for CO₂ stripping and low-shear operation. Sensor integration is via standard 12 mm and 25 mm PG13.5 ports that accept Hamilton VisiFerm and PreSens optical DO/pH, biocapacitance probes, and Raman spectroscopy flow cells. Published engineering characterisation by Kreitmayer et al. (2022, Bioengineering) for the XDR-10 reports mixing times below 30 s across all tested conditions and kLa up to 22.1 h−¹, confirming "hydrodynamic conditions well suited for the cultivation of animal cells despite the unusual design of a single bottom-mounted impeller and an unbaffled cultivation bioreactor." An optional perfusion-specific biocontainer loading door is available for the 1,000 L and 2,000 L systems to accommodate external ATF or TFF cell retention devices, and the 1,000 L and 2,000 L systems ship with a semi-automatic hoist that simplifies biocontainer installation. Control uses Cytiva's DeltaV configuration or an Allen-Bradley PLC/PAC with AVEVA HMI on the XDR-2000.
When Xcellerex wins
Cytiva wins when the downstream train is Cytiva. Xcellerex XDR pairs natively with the Cytiva ReadyToProcess single-use downstream stack (MabSelect PrismA Protein A capture, ReadyMate connectors, KTA ready single-use chromatography skids), so a facility that has standardised on Cytiva's end-to-end continuous manufacturing story gets the tightest hardware and software integration by staying inside the ecosystem. Xcellerex also wins on turndown — the 5:1 turndown is standard across the full range without a separate 2:1 SKU, so seed-train planning is simpler. The optional perfusion loading door on the XDR-1000 and XDR-2000 is a purpose-built engineering feature for high-density perfusion campaigns that other vendors bolt on externally.
Pros and cons
Sartorius Biostat STR
Advantages
- Deepest CDMO installed base: Samsung Biologics, WuXi Biologics, Boehringer Ingelheim tech-transfer risk is lowest.
- Factory-integrated Repligen XCell ATF for perfusion and intensified fed-batch in Generation 3.
- Broadest single-vendor sensor and PAT ecosystem via Biobrain and BioPAT integration.
- Well-documented scale-up: De Wilde et al. 2014 characterisation covers 2 L to 2,000 L unchanged.
Disadvantages
- Ceiling at 2,000 L single-vessel; no roadmap to 5,000 L single-use.
- Turndown of 4:1 is tighter than Cytiva's 5:1 and DynaDrive's 12–20:1.
- Flexsafe STR bag lead times can stretch during industry-wide supply squeezes.
- Biobrain automation platform migration from legacy MFCS DA is not always seamless for existing users.
Thermo HyPerforma S.U.B. and DynaDrive
Advantages
- Only vendor with 3,000 L and 5,000 L single-use bioreactors on the market via DynaDrive.
- Deepest turndown at scale: 12–20:1 on DynaDrive 3,000/5,000 L, enabling seed-train consolidation.
- Two S.U.B. turndown geometries (5:1 tall for microbial/HCD and 2:1 wide for shear-sensitive) with matched BPC bags.
- Strong microbial fermentation variant (SUF) with kLa greater than 600 h−¹.
Disadvantages
- Two families to learn: classic S.U.B. and DynaDrive have different geometries and control paradigms.
- Weaker CDMO tech-transfer story than Sartorius outside the Thermo-adjacent fleet.
- Native cell retention is external (via HyPerforma perfusion recirculation) rather than factory-integrated.
- Automation stack has fragmented origins (DASGIP-derived + Thermo controller) and requires per-site standardisation.
Cytiva Xcellerex XDR
Advantages
- Tightest integration with Cytiva ReadyToProcess single-use downstream for end-to-end continuous manufacturing.
- Consistent 5:1 turndown across the full XDR-10 to XDR-2000 range simplifies seed-train planning.
- Purpose-built perfusion biocontainer loading door on XDR-1000 and XDR-2000.
- Off-centre impeller design provides asymmetric flow and effective gas dispersion at low agitation.
Disadvantages
- Ceiling at 2,000 L single-vessel; no path to 5,000 L single-use.
- Smaller CDMO installed base than Sartorius; tech transfer often requires geometry-adaptation.
- Off-centred, unbaffled design is less familiar to engineers trained on Rushton/Sartorius centre-line geometry.
- Automation stack (DeltaV or AVEVA + Allen-Bradley) can be heavy for small biotech users who do not need process-control-system depth.
Which vendor should you choose?
Pick based on the dominant constraint: CDMO tech-transfer risk, scale ceiling, downstream integration, or perfusion architecture.
CDMO manufacturing at Samsung, WuXi, or BI
Tech transfer risk dominates the decision. Biostat STR is the reference geometry at the largest mAb CDMO fleet, so identical PD-to-commercial scale-up minimises characterisation work.
Choose Sartorius Biostat STRNeed to scale past 2,000 L single-use
High-titer mAb or vaccine programme requiring 3,000–5,000 L single-use to defer stainless-steel capex, or a seed train that benefits from 12–20:1 turndown to consolidate generations.
Choose Thermo HyPerforma DynaDriveEnd-to-end continuous / X-platform downstream
Facility standardised on Cytiva ReadyToProcess Protein A capture, KTA single-use chromatography, and integrated continuous downstream. Xcellerex XDR is the native upstream anchor.
Choose Cytiva Xcellerex XDRPerfusion or intensified fed-batch
Programme needs factory-integrated XCell ATF cell retention for perfusion or N-1 seed intensification. Biostat STR Generation 3 offers the tightest ATF hardware/software integration.
Choose Sartorius Biostat STR (Gen 3)Real-world use cases
How process teams typically converge on one vendor for a specific problem.
Sartorius Biostat STR at a Tier-1 CDMO
A clinical mAb programme entering Phase 2/3 with a CDMO manufacturing plan at Samsung Biologics or WuXi Biologics. Biostat STR is already qualified at the CDMO site, so the PD lab installs the matching 50 L or 200 L Biostat STR to eliminate geometry-adaptation work.
Thermo HyPerforma DynaDrive for facility flex
A high-titer commercial mAb needs 5,000–10,000 kg/year but the facility strategy is single-use for changeover flexibility and lower cleaning-validation burden. Two DynaDrive 5,000 L vessels replace the classic 4× 2,000 L stainless-steel approach.
Cytiva Xcellerex XDR into ReadyToProcess
A perfusion mAb programme pairs an XDR-500 with the perfusion biocontainer door and TFF cell retention, feeding directly into a Cytiva ReadyToProcess Protein A capture skid and continuous downstream train. Single-vendor integration reduces validation scope.
Any vendor — qualified sensor stack matters more
For a vaccine or AAV programme at 200 L working volume, all three platforms deliver equivalent hydrodynamics. The decision usually comes down to which vendor's sensor stack (optical DO/pH, biocapacitance, Raman) is already qualified in the process quality system.
Not sure which sensor stack fits your Biostat STR, HyPerforma, or Xcellerex line?
The Bioreactor Sensor Selection Tool asks 6 questions about your scale, modality, and PAT ambition and returns a ranked shortlist of optical DO, pH, biocapacitance, and Raman probes qualified across all three single-use bioreactor platforms.
Open the Sensor Selection ToolCost and lifecycle considerations
Capital cost for a fully instrumented 2,000 L single-use bioreactor system is USD 0.6–1.2 million per line, but over a 3-year window with 30 batches per year the bag consumables (USD 4,000–8,000 per batch), reusable-sensor calibrations, and labour dominate at roughly 65–75% of TCO. Optimising the wrong cost lever wastes engineering effort.
All three vendors price their 2,000 L systems in the USD 0.6–1.2 million range for a fully instrumented line (vessel holder, control tower, DO/pH/temperature/pressure sensors, master station). Sartorius and Cytiva typically land at the higher end when bundled with their proprietary sensor and automation ecosystems (BioPAT, DeltaV); Thermo's classic HyPerforma S.U.B. is often the lowest-capex option, though DynaDrive at 5,000 L is a separate capital tier.
Bag consumables are the recurring cost. A 2,000 L Flexsafe STR, HyPerforma BioProcess Container, or Xcellerex biocontainer runs USD 4,000–8,000 per batch depending on sensor and impeller configuration. At 30 batches per year over 3 years that is USD 360,000–720,000 in bag spend alone per line. Reusable optical DO/pH sensors (Hamilton VisiFerm, PreSens) amortise across ~50–100 batches; single-use sensor patches for optical DO/pH add roughly USD 100–300 per batch.
Labour and QC cost tracks batch count and staffing model. Assume USD 500,000–1,000,000 over 3 years per 2,000 L line for shift operators, QA release testing, and environmental monitoring. For a full 3-year, 30-batch/year 2,000 L line the total cost of ownership sits at roughly USD 2.0–3.7 million. The crossover point where stainless-steel becomes cheaper is 2,000–5,000 L working volume with 30+ batches per year — see the dedicated single-use vs stainless-steel cost comparison and the Fermentation Economics Calculator for the model.
| Cost component (3 yrs, 30 batches/yr, 2,000 L) | Sartorius Biostat STR | Thermo HyPerforma S.U.B. | Cytiva Xcellerex XDR |
|---|---|---|---|
| Capital (vessel + control tower + sensors) | USD 0.8–1.2M | USD 0.6–1.0M | USD 0.8–1.2M |
| Bag consumables (USD 4k–8k × 90) | USD 0.36–0.72M (Flexsafe STR) | USD 0.36–0.72M (BPC) | USD 0.36–0.72M (Xcellerex) |
| Sensor amortisation + patches | USD 0.1–0.3M | USD 0.1–0.3M | USD 0.1–0.3M |
| Labour + QA release | USD 0.5–1.0M | USD 0.5–1.0M | USD 0.5–1.0M |
| 3-year TCO estimate | USD 1.8–3.2M | USD 1.6–3.0M | USD 1.8–3.2M |
Vendor landscape
Beyond the big three, the single-use stirred-tank market includes several credible alternative and complementary vendors. Sartorius, Thermo Fisher, and Cytiva together hold just over 45% of 2024 revenue; the remainder is fragmented.
Sartorius platform
- Biostat STR Generation 3: 50, 200, 500, 1,000, 2,000 L; the reference workhorse for mammalian cell culture across the largest CDMO fleet.
- Biostat STR Microbial: microbial fermentation variant with elevated kLa and higher heat-removal capacity for E. coli and Pichia expression.
- Sartorius ambr 250 / ambr 15: automated micro-bioreactor systems for PD and cell-line screening that share Sartorius scale-up mathematics with the Biostat STR.
Thermo Fisher platform
- HyPerforma S.U.B.: 50–2,000 L classic cylindrical single-use bioreactor with 2:1 and 5:1 turndown BPC bags.
- HyPerforma DynaDrive: 50, 500, 3,000, 5,000 L cube-shaped multi-impeller platform — the only 5,000 L single-use bioreactor commercially available.
- HyPerforma SUF (Single-Use Fermentor): microbial fermentation variant with kLa exceeding 600 h−¹.
Cytiva platform
- Xcellerex XDR: XDR-10 through XDR-2000 with consistent 5:1 turndown and off-centred bottom impeller; refreshed X-platform SKUs at 500 L and 2,000 L (March 2025).
- ReadyToProcess WAVE 25: rocking-motion single-use bioreactor to 25 L for seed train and small-scale cell therapy.
- iCELLis fixed-bed: fixed-bed single-use bioreactor to 500 m² surface area for adherent cell culture, particularly viral vector.
Alternative vendors (the remaining ~55% of the market)
- Merck Millipore Mobius: 3 L to 2,000 L single-use bioreactor family with integrated MyControl software.
- ABEC Custom Single Run (CSR): the largest single-use bioreactors on the market (up to 6,000 L custom); typically deployed for high-titer mAb and vaccine campaigns.
- Getinge/Applikon AppliFlex STR: 40–1,000 L single-use bioreactor with the AppliFlex direct-drive design (formerly Applikon).
- Eppendorf BioBLU: single-use bioreactor vessels from 0.3 L to 40 L, popular in PD labs and academic settings.
- PBS Biotech PBS single-use: vertical-wheel single-use bioreactors from 3 L to 2,000 L targeting cell therapy and viral vector.
Frequently asked questions
What is the difference between Sartorius Biostat STR, Thermo HyPerforma S.U.B., and Cytiva Xcellerex XDR?
What working volumes are available for each single-use bioreactor?
Which single-use bioreactor has the best mixing time and kLa performance?
What is the market share of Sartorius, Thermo Fisher, and Cytiva in single-use bioreactors?
How does HyPerforma DynaDrive compare to a classic single-use bioreactor?
Which single-use bioreactor is best for perfusion or intensified fed-batch?
What is the total cost of ownership for a 2,000 L single-use bioreactor?
Can I run all three single-use bioreactors with the same third-party PAT and sensors?
Resources and references
- De Wilde et al. (2014). Superior scalability of single-use bioreactors. BioProcess International. — peer-reviewed characterisation of Biostat STR mixing time (2–20 s from 2 L to 2,000 L) and kLa (up to 40 h−¹ at 2,000 L with microsparger).
- Kreitmayer D et al. (2022). CFD-Based and Experimental Hydrodynamic Characterization of the Single-Use Bioreactor Xcellerex XDR-10. Bioengineering (Basel) 9(1):22. — peer-reviewed hydrodynamic and mass-transfer characterisation of Xcellerex XDR-10 confirming mixing <30 s and kLa up to 22.1 h−¹.
- HyPerforma 5:1 Single-Use Bioreactor Family Brochure (Thermo Fisher Scientific). — vendor datasheet covering the 50–2,000 L classic S.U.B. family including impeller design, sparger options, and turndown geometries.
- Mordor Intelligence. Single-use Bioreactor Market Size, Growth, Share & Report Analysis. — industry market-share and CAGR data underlying the 2024 USD 4.58 billion market value and vendor share estimates.